Furthermore, Galectin-9 has been recognized as a crucial positive regulator of mucosal immunity in combatting gut inflammation caused by the microbiome through the Th17-IgA axis (25), establishing an additional connection for ATXN3 in suppressing inflammation-induced colon cancer. This evidence concerns the gene CD79A and colonic neoplasm.